Vaccinex Faces Delisting Concerns
Ticker: VCNX · Form: 8-K · Filed: Apr 12, 2024 · CIK: 1205922
| Field | Detail |
|---|---|
| Company | Vaccinex, Inc. (VCNX) |
| Form Type | 8-K |
| Filed Date | Apr 12, 2024 |
| Risk Level | high |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $2.5 million, $35 million, $500,000 |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, compliance
Related Tickers: VCNX
TL;DR
Vaccinex might get kicked off NASDAQ. Big trouble.
AI Summary
Vaccinex, Inc. filed an 8-K on April 12, 2024, to report a notice of delisting or failure to satisfy a continued listing rule or standard. The company is based in Rochester, NY, and its fiscal year ends on December 31st. The filing indicates a potential issue with its listing status on NASDAQ.
Why It Matters
This filing signals potential financial distress or non-compliance with exchange rules, which could significantly impact the company's stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the company's ability to trade on a major exchange, posing a significant risk to its operations and stock value.
Key Players & Entities
- Vaccinex, Inc. (company) — Registrant
- NASDAQ (company) — Stock Exchange
- April 11, 2024 (date) — Earliest event reported
- April 12, 2024 (date) — Date of Report
- 1895 Mount Hope Avenue, Rochester, New York 14620 (location) — Principal executive offices
FAQ
What specific listing rule or standard has Vaccinex, Inc. failed to satisfy?
The filing does not specify the exact rule or standard that Vaccinex, Inc. has failed to satisfy, only that it is a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard'.
What is the date of the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing is April 11, 2024.
What is the principal executive office address for Vaccinex, Inc.?
The principal executive office address for Vaccinex, Inc. is 1895 Mount Hope Avenue, Rochester, New York 14620.
What is the Commission File Number for Vaccinex, Inc.?
The Commission File Number for Vaccinex, Inc. is 001-38624.
What is the IRS Employer Identification Number for Vaccinex, Inc.?
The IRS Employer Identification Number for Vaccinex, Inc. is 16-1603202.
Filing Stats: 626 words · 3 min read · ~2 pages · Grade level 13.6 · Accepted 2024-04-12 16:17:08
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share VCNX Nasdaq Capital Marke
- $2.5 million — ule 5550(b)(1) to maintain a minimum of $2.5 million in stockholders' equity for continued l
- $35 million — a market value of listed securities of $35 million or net income from continuing operation
- $500,000 — et income from continuing operations of $500,000 in the most recently completed fiscal y
Filing Documents
- d719945d8k.htm (8-K) — 23KB
- 0001193125-24-094701.txt ( ) — 138KB
- vcnx-20240411.xsd (EX-101.SCH) — 3KB
- vcnx-20240411_lab.xml (EX-101.LAB) — 17KB
- vcnx-20240411_pre.xml (EX-101.PRE) — 11KB
- d719945d8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Vaccinex, Inc. Date: April 12, 2024 By: /s/ Jill Sanchez Jill Sanchez Chief Financial Officer